SEC Company Response from REPLIGEN CORP (RGEN) (CIK 0000730272) (RGEN) — Jan 9, 2017
REPLIGEN CORP (RGEN) (CIK 0000730272)
Date: Jan. 9, 2017 · CIK: 0000730272 · Accession: 0001193125-17-005121
AI Filing Summary & Sentiment
Referenced dates: December 22, 2016
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 9, 2017 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549-3720 RE: Repligen Corporation Form 10-K for year ended December 31, 2015 Filed February 25, 2016 File No. 0-14656 Ladies and Gentlemen: Repligen Corporation (the “Company”) hereby advises the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) that the Company has received the Staff’s letter dated December 22, 2016 (the “Comment Letter”), regarding the Commission’s review of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015. The Comment Letter requests that the Company respond within ten (10) business days from the date thereof, or inform the Staff of when the Company would provide a response. The Company respectfully requests an extension of an additional ten (10) business days until January 24, 2017 to respond to the Comment Letter in order to provide sufficient time for the Company to prepare the necessary response. The Company is committed to responding to the Comment Letter promptly and intends to provide a response to the Staff no later than January 24, 2017. Should you have any questions regarding the request made herein, please do not hesitate to contact me at (781) 419-1862. Thank you very much for your courtesy and cooperation in this matter. Sincerely, /s/ Jon Snodgres Jon Snodgres Chief Financial Officer cc: Arthur R. McGivern – Goodwin Procter LLP